Results 31 to 40 of about 779,573 (302)

Prolonged migraine aura: new insights from a prospective diary-aided study

The Journal of Headache and Pain, 2018
Background There is limited literature on prolonged aura (PA - defined as an aura including at least one symptom for > 1 h and  4 h (n = 14) with the the others (n = 193 and n = 202 respectively). Conclusion PAs are quite common.
Michele Viana, Grazia Sances, Mattias Linde, Giuseppe Nappi, Farihah Khaliq, Peter J. Goadsby, Cristina Tassorelli   +6 more
doaj   +1 more source

Occipital nerve stimulation for headache disorders [PDF]

, 2010
Occipital nerve stimulation (ONS) was originally described in the treatment of occipital neuralgia. However, the spectrum of possible indications has expanded in recent years to include primary headache disorders, such as migraine and cluster headaches ...
Bartsch, Thorsten, Paemeleire, Koen
core   +2 more sources

Features of aura in paediatric migraine diagnosed using the ICHD 3 beta criteria [PDF]

, 2017
Background In children and adolescents, the prevalence rate of migraine with aura is 1.6%. Few studies concerning migraine with aura features in paediatric population have been reported.
Balestri, Martina, Battan, Barbara, Capuano, Alessandro, Maiorani, Daniela, Papetti, Laura, Tarantino, Samuela, Valeriani, Massimiliano, Vigevano, Federico   +7 more
core   +1 more source

Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches

Toxins, 2023
OnabotulinumtoxinA (BonT-A) reduces migraine frequency in a considerable portion of patients with migraine. So far, predictive characteristics of response are lacking. Here, we applied machine learning (ML) algorithms to identify clinical characteristics
Daniele Martinelli, Maria Magdalena Pocora, Roberto De Icco, Marta Allena, Gloria Vaghi, Grazia Sances, Gloria Castellazzi, Cristina Tassorelli   +7 more
doaj   +1 more source

Disturbances in ocular sympathetic function and facial blood flow in unilateral migraine headache [PDF]

, 1990
The relationship between thermographic asymmetry in various parts of the face and indices of ocular sympathetic outflow was examined in 80 patients with unilateral migrainous headache.
Drummond, P.D.
core   +2 more sources

Occipital Nerve Stimulation in Chronic Migraine: The Relationship Between Perceived Sensory Quality, Perceived Sensory Location, and Clinical Efficacy—A Prospective, Observational, Non-Interventional Study

Pain and Therapy, 2020
Introduction Occipital nerve stimulation (ONS) is used to treat therapy-resistant chronic migraine. Clinical use has resulted in a wide intraindividual and interindividual variation of clinical efficacy.
Carl H. Göbel, Anna Göbel, Uwe Niederberger, Axel Heinze, Katja Heinze-Kuhn, Christoph Meinecke, Hubertus M. Mehdorn, Dirk Rasche, Hartmut Göbel   +8 more
doaj   +1 more source

Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence

The Journal of Headache and Pain, 2023
Objective To explore and critically appraise the evidence supporting the role of estrogen withdrawal in menstrual migraine. Main body Menstrual migraine, impacting about 6% of reproductive-age women, manifests as migraine attacks closely related to the ...
Bianca Raffaelli, Thien Phu Do, Basit Ali Chaudhry, Messoud Ashina, Faisal Mohammad Amin, Håkan Ashina   +5 more
doaj   +1 more source

Self-efficacy and medicine use for headache among adolescents in Italy: results from the Italian HBSC 2010 study [PDF]

, 2015
This article aims first to investigate gender patterns in medicine use, and corresponding headache complaints, in Italian adolescents; second, to examine the association between self-efficacy and medicine use for headache.
Cavallo, Franco, Marino, Claudia, Santinello, Massimo, Vieno, Alessio   +3 more
core   +1 more source

In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study

The Journal of Headache and Pain, 2021
Background Patient-Reported Outcomes (PROs) have been developed to numerically quantify disability, impact and quality of life. They have been widely used in migraine clinical trials.
Alicia Alpuente, Victor J Gallardo, Edoardo Caronna, Marta Torres-Ferrus, Patricia Pozo-Rosich   +4 more
doaj   +1 more source

Fremanezumab for the Preventive Treatment of Chronic Migraine. [PDF]

, 2017
BACKGROUND: Fremanezumab, a humanized monoclonal antibody targeting calcitonin gene-related peptide (CGRP), is being investigated as a preventive treatment for migraine.
Aycardi, Ernesto, Bigal, Marcelo E., Blankenbiller, Tricia, Dodick, David W., Goadsby, Peter J., Grozinski-Wolff, Melissa, Ma, Yuju, Silberstein, Stephen D., Yang, Ronghua, Yeung, Paul P.   +9 more
core   +2 more sources